Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Munich - Delayed Quote • EUR Exact Sciences Corp (EXK.MU) Follow Add holdings 39.99 +0.75 +(1.90%) As of 5:26:05 PM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for EXK.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: EXK.MU View More All News Press Releases SEC Filings This Exact Sciences Insider Increased Their Holding In The Last Year Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential 2 Reasons to Like EXAS (and 1 Not So Much) How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It. Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers Tap Into the Silver Economy Boom With These Aging Demographics Stocks JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)